Article
Quick COVID-19 Healers Sustain Anti-SARS-CoV-2 Antibody Production.
Cell - 10 Dec 2020
Chen Yuezhou, Zuiani Adam, Fischinger Stephanie, Mullur Jyotsna, Atyeo Caroline, Travers Meghan, Lelis Felipe J N, Pullen Krista M, Martin Hannah, Tong Pei, Gautam Avneesh, Habibi Shaghayegh, Bensko Jillian, Gakpo Deborah, Feldman Jared, Hauser Blake M, Caradonna Timothy M, Cai Yongfei, Burke John S, Lin Junrui, Lederer James A, Lam Evan Christopher, Lavine Christy L, Seaman Michael S, Chen Bing, Schmidt Aaron G, Balazs Alejandro Benjamin, Lauffenburger Douglas A, Alter Galit, Wesemann Duane R
Abstract excerpt
Antibodies are key immune effectors that confer protection against pathogenic threats. The nature and longevity of the antibody response to SARS-CoV-2 infection are not well defined. We charted longitudinal antibody responses to SARS-CoV-2 in 92 subjects after symptomatic COVID-19. Antibody responses to SARS-CoV-2 are unimodally distributed over a broad range, with symptom severity correlating directly with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
